Case 1 | 27 | M | Abdomen and back | Pruritic and erythematous linear | Mixed germ cell intra-abdominal malignant tumour | Bleomycin, etoposide and cisplatin | Methylprednisolone and cetirizine |
Case 2 | 17 | F | Abdomen, waist and back | Pruritic, erythematous and hyperpigmentation linear | Osteosarcoma | HDMTX, bleomycin, cyclophosphamide, doxorubicin and cisplatin | Cetirizine and desoximetasone |
Grynszpan et al1 | 40 | F | Lower limb and back | Pruritic, erythematous lesion and hyperpigmentation | Hodgkin’s lymphoma | Adriamycin, vinblastine, dacarbazine and bleomycin | – |
Boussios et al2 | 20 | F | Chest and upper back | Striking linear configuration and post-inflammatory hyperpigmentation | Ovarian cyst | Bleomycin, etoposide and cisplatin | – |
Adjade et al4 | 37 | M | Trunk | Linear flagellate erythema | Testicular seminoma | Bleomycin, etoposide and cisplatin | Oral corticoid and antihistamine |
Turan Erkek6 | 24 | F | Back, shoulders and trunk | Papules and plaques remarkable whip-like mark formation | Hodgkin lymphoma | Doxorubicin, bleomycin, vincristine, cyclophosphamide, etoposide, prednisone and procarbazine | – |
Krajewski et al8 | 33 | M | Back and shoulders | Pruritic and linear hyperpigmentation | Seminoma | Bleomycin, etoposide and cisplatin | – |
Cullingham et al 9 | 32 | M | Back | Pruritic and linear rash | Seminoma | Bleomycin, etoposide and cisplatin | Hydroxyzine and replace bilastine, desoximetasone |
Biswas et al11 | 13 | M | Trunk and upper extremities | Linear erythematous | Thalamic mixed germ cell tumour | Bleomycin, etoposide and cisplatin | Cetirizine and betametason topical |